HDA comments to FDA on state of industry’s readiness for DSCSA deadline
HDA submitted comments on Tuesday to the FDA in response to the agency’s request for information, “Implementing Interoperable Systems and Processes for Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act” (RFI),” which asks how tradin